Keyphrases
Irritable Bowel Syndrome
100%
Diarrhea-predominant Irritable Bowel Syndrome
100%
Pain Management
100%
Abdominal Pain
100%
Short-chain Fatty Acids
100%
Glucagon-like peptide-1 (GLP-1)
100%
Gut Microbiota
40%
Visceral Hypersensitivity
33%
Fecal Short-chain Fatty Acids
20%
Fatty Acid Composition
20%
GLP-1 Signalling
13%
Pain Symptoms
13%
Gut Metabolites
13%
Signaling Axis
13%
Fecal Microbiota Transplantation
13%
GLP-1 Secretion
6%
Dominant Symptom
6%
Microbial Abundance
6%
Genomic Variants
6%
Regulatory Role
6%
Enteroendocrine Cells
6%
Microbiome
6%
Bacterial Genomes
6%
Novel Therapeutics
6%
Mouse Model
6%
Molecular Mechanism
6%
Pain Index
6%
Abdominal Distension
6%
Bloating
6%
Functional Bowel Disorders
6%
Butyrate
6%
Host-microbe
6%
Visceral Sensitivity
6%
Novel Therapies
6%
Conventional Medication
6%
IBS Symptoms
6%
Acetate
6%
GLP-1 Receptor Agonist
6%
Propionate
6%
Glucagon-like
6%
Clinical Investigation
6%
Diarrhea
6%
Medicine and Dentistry
Short Chain Fatty Acid
100%
Abdominal Pain
100%
Irritable Bowel Syndrome
100%
Diarrhea
100%
Glucagon Like Peptide 1
100%
Analgesia
100%
Gut Microbiota
40%
Hypersensitivity
33%
Gut
20%
Pain (Symptom)
13%
Metabolite
13%
Propionic Acid
6%
Glucagon-Like Peptide-1 Agonist
6%
Butyric Acid
6%
Microbiome
6%
Clinical Study
6%
Secretion (Process)
6%
Enteropathy
6%
Acetic Acid
6%
Host Cell
6%
Bloating
6%
Pharmacology, Toxicology and Pharmaceutical Science
Diarrhea
100%
Short Chain Fatty Acid
100%
Glucagon-Like Peptide-1
100%
Irritable Colon
100%
Abdominal Pain
100%
Intestine Flora
40%
Erethism
33%
Feces microflora
13%
Microorganism
6%
Mouse Model
6%
Microbiome
6%
Clinical Study
6%
Butyrate
6%
Bloating
6%
Propionic Acid
6%
Enteropathy
6%
Glucagon Like Peptide 1 Receptor Agonist
6%